Ellen Rosenberg Amicus Therapeutics, Inc. (FOLD) insider trading activity

Ellen Rosenberg is Chief Legal Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 507,710 shares of FOLD, which is worth approximately $4.58 Million. The most recent transaction as insider was on Jan 04, 2023, when has been sold 3,575 shares (Common Stock) at a price of $12.03 per share, resulting in proceeds of $43,007. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 508K

38.09% 3M change

38.09% 12M change

Total Value Held $4.58 Million

Ellen Rosenberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 04 2023	SELL Payment of exercise price or tax liability	$43,007 $12.03 p/Share	3,575 Reduced 1.06%	332,345 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$94,163 $11.93 p/Share	7,893 Reduced 2.3%	335,920 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	77,749 Added 18.44%	343,813 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$178,791 $12.21 p/Share	14,643 Reduced 5.22%	266,064 Common Stock
Aug 01 2022	SELL Open market or private sale	$111,452 $10.02 p/Share	11,123 Reduced 3.81%	280,707 Common Stock
Jun 21 2022	SELL Open market or private sale	$111,220 $10.0 p/Share	11,122 Reduced 3.67%	291,830 Common Stock
Apr 07 2022	SELL Open market or private sale	$99,823 $9.06 p/Share	11,018 Reduced 3.51%	302,952 Common Stock
Jan 14 2022	SELL Payment of exercise price or tax liability	$177,936 $10.53 p/Share	16,898 Reduced 5.11%	313,970 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	39,143 Added 10.58%	330,868 Common Stock
Jan 04 2022	SELL Payment of exercise price or tax liability	$44,616 $12.48 p/Share	3,575 Reduced 1.21%	291,725 Common Stock
Jan 03 2022	SELL Payment of exercise price or tax liability	$35,967 $12.11 p/Share	2,970 Reduced 1.32%	222,164 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	73,136 Added 19.85%	295,300 Common Stock
Jan 02 2022	SELL Payment of exercise price or tax liability	$76,103 $11.55 p/Share	6,589 Reduced 2.84%	225,134 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$109,529 $11.55 p/Share	9,483 Reduced 3.93%	231,723 Common Stock
Apr 06 2021	BUY Grant, award, or other acquisition	-	20,501 Added 7.83%	241,206 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$192,061 $21.84 p/Share	8,794 Reduced 3.83%	220,705 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	20,731 Added 8.28%	229,499 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	33,131 Added 13.7%	208,768 Common Stock
Jan 03 2021	SELL Payment of exercise price or tax liability	$191,786 $23.09 p/Share	8,306 Reduced 4.52%	175,637 Common Stock
Jan 02 2021	SELL Payment of exercise price or tax liability	$149,508 $23.09 p/Share	6,475 Reduced 3.4%	183,943 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$109,701 $23.09 p/Share	4,751 Reduced 2.43%	190,418 Common Stock

Ellen Rosenberg

Chief Legal Officer

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account